 | Up a level |
2017
Eichenauer, Dennis A., Pluetschow, Annette, Kreissl, Stefanie, Soekler, Martin, Hellmuth, Johannes C. 
ORCID: 0000-0001-8409-3037, Meissner, Julia, Mathas, Stephan, Topp, Max S., Behringer, Karolin, Klapper, Wolfram, Kuhnert, Georg, Dietlein, Markus, Kobe, Carsten, Fuchs, Michael, Diehl, Volker, Engert, Andreas and Borchmann, Peter
(2017).
Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group.
Lancet Oncol., 18 (12).
S. 1680 - 1688.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-5488
2015
Borchmann, Peter, Eichenauer, Dennis A., Pluetschow, Annette, Haverkamp, Heinz, Kreissl, Stefanie, Fuchs, Michael, Soekler, Martin, Hellmuth, Johannes C., Meissner, Julia, Mathas, Stephan, Behringer, Karolin, Dietlein, Markus, Kobe, Carsten, Diehl, Volker and Engert, Andreas (2015). Targeted Beacopp Variants in Patients with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma: Final Analysis of a Randomized Phase II Study. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020